Effects of an Interprofessional Communication Approach on Support Needs, Quality of Life, and Mood of Patients with Advanced Lung Cancer: A Randomized Trial.
Communication
Lung cancer
Needs
Quality of life
Support
Journal
The oncologist
ISSN: 1549-490X
Titre abrégé: Oncologist
Pays: England
ID NLM: 9607837
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
18
12
2020
accepted:
02
04
2021
pubmed:
17
4
2021
medline:
29
9
2021
entrez:
16
4
2021
Statut:
ppublish
Résumé
To address the support needs of newly diagnosed patients with lung cancer with limited prognosis, the Milestone Communication Approach (MCA) was developed and implemented. The main elements of the MCA are situation-specific conversations along the disease trajectory conducted by an interprofessional tandem of physician and nurse. The aim of the study was to evaluate the effects of MCA on addressing support needs, quality of life, and mood as compared with standard oncological care. A randomized trial was conducted with baseline assessment and follow-up assessments at 3, 6, and 9 months in outpatients with newly diagnosed lung cancer stage IV at a German thoracic oncology hospital. The primary outcome was the Health System and Information Needs subscale of the Short Form Supportive Care Needs Survey (SCNS-SF34-G) at 3-month follow-up. Secondary outcomes included the other subscales of the SCNS-SF34-G, the Schedule for the Evaluation of Individual Quality of Life, the Functional Assessment of Cancer Therapy lung module, the Patient Health Questionnaire for Depression and Anxiety, and the Distress Thermometer. At baseline, 174 patients were randomized, of whom 102 patients (MCA: n = 52; standard care: n = 50) provided data at 3-month follow-up. Patients of the MCA group reported lower information needs at 3-month follow-up (mean ± SD, 33.4 ± 27.5; standard care, 43.1 ± 29.9; p = .033). No effects were found for secondary outcomes. MCA lowered patient-reported information needs but did not have other effects. MCA contributed to tailored communication because an adequate level of information and orientation set the basis for patient-centered care. By addressing relevant issues at predefined times, the Milestone Communication Approach provides individual patient-centered care facilitating the timely integration of palliative care for patients with a limited prognosis. The needs of patients with lung cancer must be assessed and addressed throughout the disease trajectory. Although specific topics may be relevant for all patients, such as information about the disease and associated health care, situations of individual patients and their families must be considered. Additionally, using the short form of the Supportive Care Needs Survey in clinical practice to identify patients' problems might support individually targeted communication and preference-sensitive care.
Sections du résumé
BACKGROUND
To address the support needs of newly diagnosed patients with lung cancer with limited prognosis, the Milestone Communication Approach (MCA) was developed and implemented. The main elements of the MCA are situation-specific conversations along the disease trajectory conducted by an interprofessional tandem of physician and nurse. The aim of the study was to evaluate the effects of MCA on addressing support needs, quality of life, and mood as compared with standard oncological care.
PATIENTS AND METHODS
A randomized trial was conducted with baseline assessment and follow-up assessments at 3, 6, and 9 months in outpatients with newly diagnosed lung cancer stage IV at a German thoracic oncology hospital. The primary outcome was the Health System and Information Needs subscale of the Short Form Supportive Care Needs Survey (SCNS-SF34-G) at 3-month follow-up. Secondary outcomes included the other subscales of the SCNS-SF34-G, the Schedule for the Evaluation of Individual Quality of Life, the Functional Assessment of Cancer Therapy lung module, the Patient Health Questionnaire for Depression and Anxiety, and the Distress Thermometer.
RESULTS
At baseline, 174 patients were randomized, of whom 102 patients (MCA: n = 52; standard care: n = 50) provided data at 3-month follow-up. Patients of the MCA group reported lower information needs at 3-month follow-up (mean ± SD, 33.4 ± 27.5; standard care, 43.1 ± 29.9; p = .033). No effects were found for secondary outcomes.
CONCLUSION
MCA lowered patient-reported information needs but did not have other effects. MCA contributed to tailored communication because an adequate level of information and orientation set the basis for patient-centered care.
IMPLICATIONS FOR PRACTICE
By addressing relevant issues at predefined times, the Milestone Communication Approach provides individual patient-centered care facilitating the timely integration of palliative care for patients with a limited prognosis. The needs of patients with lung cancer must be assessed and addressed throughout the disease trajectory. Although specific topics may be relevant for all patients, such as information about the disease and associated health care, situations of individual patients and their families must be considered. Additionally, using the short form of the Supportive Care Needs Survey in clinical practice to identify patients' problems might support individually targeted communication and preference-sensitive care.
Identifiants
pubmed: 33860592
doi: 10.1002/onco.13790
pmc: PMC8342586
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1445-e1459Informations de copyright
© 2021 The Authors. The Oncologist published by Wiley Periodicals LLC on behalf of AlphaMed Press.
Références
J Palliat Med. 2013 Aug;16(8):894-900
pubmed: 23786425
Eur J Health Econ. 2015 Jul;16(6):657-70
pubmed: 25135768
J Clin Oncol. 2015 May 1;33(13):1438-45
pubmed: 25800768
Oncol Nurs Forum. 2004 Mar-Apr;31(2):313-9
pubmed: 15017447
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Cancer Nurs. 2017 Jan/Feb;40(1):66-75
pubmed: 26925990
BMC Cancer. 2018 Sep 21;18(1):912
pubmed: 30241476
Qual Life Res. 2009 Aug;18(6):737-46
pubmed: 19496021
Med Sci Monit. 2018 Mar 21;24:1680-1687
pubmed: 29561832
Support Care Cancer. 2012 Oct;20(10):2415-24
pubmed: 22212457
Support Care Cancer. 2016 Nov;24(11):4639-49
pubmed: 27318479
J R Soc Med. 2003 May;96(5):219-22
pubmed: 12724430
BMC Health Serv Res. 2017 Mar 2;17(1):173
pubmed: 28253884
Z Evid Fortbild Qual Gesundhwes. 2019 Nov;147-148:28-33
pubmed: 31350189
Chron Respir Dis. 2013 Feb;10(1):35-47
pubmed: 23355404
J Oncol Pharm Pract. 2020 Nov 4;:1078155220971035
pubmed: 33148130
Support Care Cancer. 2017 Nov;25(11):3329-3338
pubmed: 28551842
BMC Palliat Care. 2020 Feb 18;19(1):21
pubmed: 32070311
BMJ Open. 2015 Oct 06;5(10):e009032
pubmed: 26443662
Oncol Res Treat. 2019;42(12):650-659
pubmed: 31634889
J Clin Oncol. 2017 Nov 1;35(31):3618-3632
pubmed: 28892432
Qual Life Res. 1996 Jun;5(3):309-20
pubmed: 8763799
Psychooncology. 2011 Dec;20(12):1292-300
pubmed: 22114044
Stat Methods Med Res. 2007 Jun;16(3):219-42
pubmed: 17621469
Eur J Oncol Nurs. 2017 Oct;30:67-74
pubmed: 29031316
Patient Prefer Adherence. 2016 Oct 03;10:2021-2029
pubmed: 27757022
Support Care Cancer. 2021 Apr;29(4):2153-2159
pubmed: 32880008
J Clin Oncol. 2017 Mar 10;35(8):834-841
pubmed: 28029308
J Eval Clin Pract. 2009 Aug;15(4):602-6
pubmed: 19522727
Oncologist. 2017 Apr;22(4):470-479
pubmed: 28275115
Health Qual Life Outcomes. 2020 Jun 23;18(1):199
pubmed: 32576289
Lung Cancer. 1995 Jun;12(3):199-220
pubmed: 7655830
Curr Oncol. 2016 Aug;23(4):258-65
pubmed: 27536176
N Engl J Med. 2010 Aug 19;363(8):733-42
pubmed: 20818875
Lancet. 2014 May 17;383(9930):1721-30
pubmed: 24559581
Oncol Res Treat. 2016;39(4):186-91
pubmed: 27160588
Eur J Cancer Care (Engl). 2018 Mar;27(2):e12794
pubmed: 29168594
Trials. 2018 Aug 14;19(1):438
pubmed: 30107809
J Affect Disord. 2010 Apr;122(1-2):86-95
pubmed: 19616305
Oncologist. 2000;5(4):302-11
pubmed: 10964998
Support Care Cancer. 2020 May;28(5):2145-2155
pubmed: 31410598
Eur J Cancer Care (Engl). 2012 Jul;21(4):450-9
pubmed: 22571471
Cochrane Database Syst Rev. 2017 Jun 12;6:CD011129
pubmed: 28603881
Health Qual Life Outcomes. 2020 Feb 17;18(1):29
pubmed: 32066444
Clin Lung Cancer. 2017 May;18(3):274-280.e6
pubmed: 28185791
Oncol Res Treat. 2019;42(1-2):41-46
pubmed: 30677754
BMJ Open. 2018 Mar 12;8(3):e019576
pubmed: 29530909
J Pain Symptom Manage. 2005 Jul;30(1):51-62
pubmed: 16043007
J Cancer Surviv. 2015 Dec;9(4):567-75
pubmed: 25676473
Oncol Nurs Forum. 2017 Nov 1;44(6):645-649
pubmed: 29052657
J Clin Oncol. 2011 Feb 20;29(6):755-60
pubmed: 21263086
Psychooncology. 2018 Sep;27(9):2132-2140
pubmed: 29802674